The Enterprise Value as of November 2024 (TTM) for Insmed Incorporated (INSM) is 13.63B

According to Insmed Incorporated’s latest financial reports and current stock price. The company's current Enterprise Value is 13.63B. This represents a change of 62.37% compared to the average of 8.39B of the last 4 quarters.

Insmed Incorporated (INSM) Historical Enterprise Value (quarterly & annually)

How has INSM Enterprise Value performed in the past?

The mean historical Enterprise Value of Insmed Incorporated over the last ten years is 2.03B. The current 13.63B Enterprise Value has changed 67.15% with respect to the historical average. Over the past ten years (40 quarters), INSM's Enterprise Value was at its highest in in the September 2024 quarter at 13.22B. The Enterprise Value was at its lowest in in the June 2016 quarter at 411.83M.

Insmed Incorporated (INSM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Insmed Incorporated Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Insmed Incorporated (INSM) Average Enterprise Value

How has INSM Enterprise Value performed in the past?

The current Enterprise Value of Insmed Incorporated (INSM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Insmed Incorporated (INSM) Enterprise Value vs. Peers

How is INSM’s Enterprise Value compared to its peers?

Insmed Incorporated’s Enterprise Value is greater than Ascendis Pharma A/S (7.61B), greater than Apellis Pharmaceuticals, Inc. (3.90B), less than BeiGene, Ltd. (19.75B), greater than Akero Therapeutics, Inc. (2.00B), greater than Blueprint Medicines Corporation (6.36B), greater than Cerevel Therapeutics Holdings, Inc. (8.24B), greater than Avidity Biosciences, Inc. (4.80B), greater than Revolution Medicines, Inc. (9.43B), greater than Day One Biopharmaceuticals, Inc. (963.46M), greater than SpringWorks Therapeutics, Inc. (2.83B), greater than Keros Therapeutics, Inc. (1.75B), greater than Janux Therapeutics, Inc. (2.64B), greater than Fennec Pharmaceuticals Inc. (105.60M), greater than Edgewise Therapeutics, Inc. (3.01B), greater than Harmony Biosciences Holdings, Inc. (1.74B), greater than Halozyme Therapeutics, Inc. (7.58B), greater than Agios Pharmaceuticals, Inc. (2.98B), greater than Ultragenyx Pharmaceutical Inc. (4.24B),

Build a custom stock screener for Insmed Incorporated (INSM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Insmed Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Insmed Incorporated (INSM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Insmed Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.